Tags
The third-largest U.S. health insurer said it would offer the drug as the preferred choice to its nearly 11 million commercial customers.
from NYT > Business Day http://ift.tt/157f9GV
via IFTTThttp://ift.tt/157fcm2 http://ift.tt/IP98QF
Advertisements